ProShare Advisors LLC Acquires New Holdings in Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB)
ProShare Advisors LLC acquired a new stake in shares of Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB – Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 12,645 shares of the company’s stock, valued at approximately $99,000. Several other institutional investors also recently […]
ProShare Advisors LLC acquired a new stake in shares of Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB – Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 12,645 shares of the company’s stock, valued at approximately $99,000. Several other institutional investors also recently […]
